 | • レポートコード：QYR9ST02016 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の癌温熱療法市場について調査・分析し、以下の構成でお届け致します。癌温熱療法の種類別には、マイクロ波温熱治療器、超音波温熱治療器、赤外線治療器、短波治療器に、用途別には、病院、診療所、研究所に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別癌温熱療法売上データ ・地域別癌温熱療法市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別癌温熱療法市場規模：マイクロ波温熱治療器、超音波温熱治療器、赤外線治療器、短波治療器 ・用途別癌温熱療法市場規模：病院、診療所、研究所 ・主要メーカーの企業情報：Andromedic Sri、Celsius42 GmbH、Huahang、Pyrexar Medical、Perseon Medical、Omron Corporation、Sjn AG Yamamoto Vinita ・癌温熱療法の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
The global Hyperthermia Treatment for Cancer market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hyperthermia Treatment for Cancer market based on company, product type, end user and key regions.
This report studies the global market size of Hyperthermia Treatment for Cancer in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hyperthermia Treatment for Cancer in these regions.
This research report categorizes the global Hyperthermia Treatment for Cancer market by top players/brands, region, type and end user. This report also studies the global Hyperthermia Treatment for Cancer market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Andromedic Sri
Celsius42 GmbH
Huahang
Pyrexar Medical
Perseon Medical
Omron Corporation
Sjn AG Yamamoto Vinita
Market size by Product
Microwave Hyperthermia Device
Ultrasound Hyperthermia Device
Infrared Therapy Device
Short-wave Therapy Device
Market size by End User
Hospitals
Clinics
Research Institutes
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Hyperthermia Treatment for Cancer market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Hyperthermia Treatment for Cancer market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Hyperthermia Treatment for Cancer companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Hyperthermia Treatment for Cancer submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Hyperthermia Treatment for Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hyperthermia Treatment for Cancer market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Hyperthermia Treatment for Cancer Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Hyperthermia Treatment for Cancer Market Size Growth Rate by Product
1.4.2 Microwave Hyperthermia Device
1.4.3 Ultrasound Hyperthermia Device
1.4.4 Infrared Therapy Device
1.4.5 Short-wave Therapy Device
1.5 Market by End User
1.5.1 Global Hyperthermia Treatment for Cancer Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hyperthermia Treatment for Cancer Market Size
2.1.1 Global Hyperthermia Treatment for Cancer Revenue 2014-2025
2.1.2 Global Hyperthermia Treatment for Cancer Sales 2014-2025
2.2 Hyperthermia Treatment for Cancer Growth Rate by Regions
2.2.1 Global Hyperthermia Treatment for Cancer Sales by Regions
2.2.2 Global Hyperthermia Treatment for Cancer Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Hyperthermia Treatment for Cancer Sales by Manufacturers
3.1.1 Hyperthermia Treatment for Cancer Sales by Manufacturers
3.1.2 Hyperthermia Treatment for Cancer Sales Market Share by Manufacturers
3.1.3 Global Hyperthermia Treatment for Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Hyperthermia Treatment for Cancer Revenue by Manufacturers
3.2.1 Hyperthermia Treatment for Cancer Revenue by Manufacturers (2014-2019)
3.2.2 Hyperthermia Treatment for Cancer Revenue Share by Manufacturers (2014-2019)
3.3 Hyperthermia Treatment for Cancer Price by Manufacturers
3.4 Hyperthermia Treatment for Cancer Manufacturing Base Distribution, Product Types
3.4.1 Hyperthermia Treatment for Cancer Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hyperthermia Treatment for Cancer Product Type
3.4.3 Date of International Manufacturers Enter into Hyperthermia Treatment for Cancer Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Hyperthermia Treatment for Cancer Sales by Product
4.2 Global Hyperthermia Treatment for Cancer Revenue by Product
4.3 Hyperthermia Treatment for Cancer Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Hyperthermia Treatment for Cancer Breakdown Data by End User
6 North America
6.1 North America Hyperthermia Treatment for Cancer by Countries
6.1.1 North America Hyperthermia Treatment for Cancer Sales by Countries
6.1.2 North America Hyperthermia Treatment for Cancer Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Hyperthermia Treatment for Cancer by Product
6.3 North America Hyperthermia Treatment for Cancer by End User
7 Europe
7.1 Europe Hyperthermia Treatment for Cancer by Countries
7.1.1 Europe Hyperthermia Treatment for Cancer Sales by Countries
7.1.2 Europe Hyperthermia Treatment for Cancer Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hyperthermia Treatment for Cancer by Product
7.3 Europe Hyperthermia Treatment for Cancer by End User
8 Asia Pacific
8.1 Asia Pacific Hyperthermia Treatment for Cancer by Countries
8.1.1 Asia Pacific Hyperthermia Treatment for Cancer Sales by Countries
8.1.2 Asia Pacific Hyperthermia Treatment for Cancer Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Hyperthermia Treatment for Cancer by Product
8.3 Asia Pacific Hyperthermia Treatment for Cancer by End User
9 Central & South America
9.1 Central & South America Hyperthermia Treatment for Cancer by Countries
9.1.1 Central & South America Hyperthermia Treatment for Cancer Sales by Countries
9.1.2 Central & South America Hyperthermia Treatment for Cancer Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Hyperthermia Treatment for Cancer by Product
9.3 Central & South America Hyperthermia Treatment for Cancer by End User
10 Middle East and Africa
10.1 Middle East and Africa Hyperthermia Treatment for Cancer by Countries
10.1.1 Middle East and Africa Hyperthermia Treatment for Cancer Sales by Countries
10.1.2 Middle East and Africa Hyperthermia Treatment for Cancer Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Hyperthermia Treatment for Cancer by Product
10.3 Middle East and Africa Hyperthermia Treatment for Cancer by End User
11 Company Profiles
11.1 Andromedic Sri
11.1.1 Andromedic Sri Company Details
11.1.2 Company Business Overview
11.1.3 Andromedic Sri Hyperthermia Treatment for Cancer Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Andromedic Sri Hyperthermia Treatment for Cancer Products Offered
11.1.5 Andromedic Sri Recent Development
11.2 Celsius42 GmbH
11.2.1 Celsius42 GmbH Company Details
11.2.2 Company Business Overview
11.2.3 Celsius42 GmbH Hyperthermia Treatment for Cancer Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Celsius42 GmbH Hyperthermia Treatment for Cancer Products Offered
11.2.5 Celsius42 GmbH Recent Development
11.3 Huahang
11.3.1 Huahang Company Details
11.3.2 Company Business Overview
11.3.3 Huahang Hyperthermia Treatment for Cancer Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Huahang Hyperthermia Treatment for Cancer Products Offered
11.3.5 Huahang Recent Development
11.4 Pyrexar Medical
11.4.1 Pyrexar Medical Company Details
11.4.2 Company Business Overview
11.4.3 Pyrexar Medical Hyperthermia Treatment for Cancer Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Pyrexar Medical Hyperthermia Treatment for Cancer Products Offered
11.4.5 Pyrexar Medical Recent Development
11.5 Perseon Medical
11.5.1 Perseon Medical Company Details
11.5.2 Company Business Overview
11.5.3 Perseon Medical Hyperthermia Treatment for Cancer Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Perseon Medical Hyperthermia Treatment for Cancer Products Offered
11.5.5 Perseon Medical Recent Development
11.6 Omron Corporation
11.6.1 Omron Corporation Company Details
11.6.2 Company Business Overview
11.6.3 Omron Corporation Hyperthermia Treatment for Cancer Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Omron Corporation Hyperthermia Treatment for Cancer Products Offered
11.6.5 Omron Corporation Recent Development
11.7 Sjn AG Yamamoto Vinita
11.7.1 Sjn AG Yamamoto Vinita Company Details
11.7.2 Company Business Overview
11.7.3 Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Products Offered
11.7.5 Sjn AG Yamamoto Vinita Recent Development
12 Future Forecast
12.1 Hyperthermia Treatment for Cancer Market Forecast by Regions
12.1.1 Global Hyperthermia Treatment for Cancer Sales Forecast by Regions 2019-2025
12.1.2 Global Hyperthermia Treatment for Cancer Revenue Forecast by Regions 2019-2025
12.2 Hyperthermia Treatment for Cancer Market Forecast by Product
12.2.1 Global Hyperthermia Treatment for Cancer Sales Forecast by Product 2019-2025
12.2.2 Global Hyperthermia Treatment for Cancer Revenue Forecast by Product 2019-2025
12.3 Hyperthermia Treatment for Cancer Market Forecast by End User
12.4 North America Hyperthermia Treatment for Cancer Forecast
12.5 Europe Hyperthermia Treatment for Cancer Forecast
12.6 Asia Pacific Hyperthermia Treatment for Cancer Forecast
12.7 Central & South America Hyperthermia Treatment for Cancer Forecast
12.8 Middle East and Africa Hyperthermia Treatment for Cancer Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hyperthermia Treatment for Cancer Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Hyperthermia Treatment for Cancer Product Picture
Table Hyperthermia Treatment for Cancer Market Segments
Table Key Manufacturers Hyperthermia Treatment for Cancer Covered
Table Global Hyperthermia Treatment for Cancer Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Hyperthermia Treatment for Cancer Sales Market Share by Product 2014-2025
Figure Microwave Hyperthermia Device Product Picture
Table Major Manufacturers of Microwave Hyperthermia Device
Figure Ultrasound Hyperthermia Device Product Picture
Table Major Manufacturers of Ultrasound Hyperthermia Device
Figure Infrared Therapy Device Product Picture
Table Major Manufacturers of Infrared Therapy Device
Figure Short-wave Therapy Device Product Picture
Table Major Manufacturers of Short-wave Therapy Device
Table Global Hyperthermia Treatment for Cancer Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Clinics
Figure Research Institutes
Figure Hyperthermia Treatment for Cancer Report Years Considered
Figure Global Hyperthermia Treatment for Cancer Market Size 2014-2025 (Million US$)
Figure Global Hyperthermia Treatment for Cancer Sales 2014-2025 (K Units)
Table Global Hyperthermia Treatment for Cancer Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Hyperthermia Treatment for Cancer Sales by Regions 2014-2019 (K Units)
Table Global Hyperthermia Treatment for Cancer Sales Market Share by Regions 2014-2019
Figure Global Hyperthermia Treatment for Cancer Sales Market Share by Regions 2014-2019
Figure 2018 Global Hyperthermia Treatment for Cancer Sales Market Share by Regions
Table Global Hyperthermia Treatment for Cancer Revenue by Regions 2014-2019 (Million US$)
Table Global Hyperthermia Treatment for Cancer Revenue Market Share by Regions 2014-2019
Figure Global Hyperthermia Treatment for Cancer Revenue Market Share by Regions 2014-2019
Figure 2018 Global Hyperthermia Treatment for Cancer Revenue Market Share by Regions
Table Global Hyperthermia Treatment for Cancer Sales by Manufacturers (2014-2019) (K Units)
Table Global Hyperthermia Treatment for Cancer Sales Share by Manufacturers (2014-2019)
Figure Global Hyperthermia Treatment for Cancer Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Hyperthermia Treatment for Cancer Revenue by Manufacturers (2014-2019) (Million USD)
Table Hyperthermia Treatment for Cancer Revenue Share by Manufacturers (2014-2019)
Figure Hyperthermia Treatment for Cancer Value Share by Manufacturers in 2018
Table Key Manufacturers Hyperthermia Treatment for Cancer Price (2014-2019) (USD/Unit)
Table Hyperthermia Treatment for Cancer Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Hyperthermia Treatment for Cancer Product Type
Table Date of International Manufacturers Enter into Hyperthermia Treatment for Cancer Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Hyperthermia Treatment for Cancer Sales by Product (2014-2019) (K Units)
Table Global Hyperthermia Treatment for Cancer Sales Share by Product (2014-2019)
Figure Global Hyperthermia Treatment for Cancer Sales Market Share by Product (2014-2019)
Figure Global Hyperthermia Treatment for Cancer Sales Market Share by Product in 2018
Table Global Hyperthermia Treatment for Cancer Revenue by Product (2014-2019) (Million US$)
Table Global Hyperthermia Treatment for Cancer Revenue Share by Product (2014-2019)
Figure Global Hyperthermia Treatment for Cancer Revenue Market Share by Product (2014-2019)
Figure Global Hyperthermia Treatment for Cancer Revenue Market Share by Product in 2018
Table Hyperthermia Treatment for Cancer Price by Product 2014-2019 (USD/Unit)
Table Global Hyperthermia Treatment for Cancer Sales by End User (2014-2019) (K Units)
Table Global Hyperthermia Treatment for Cancer Sales Share by End User (2014-2019)
Figure Global Sales Hyperthermia Treatment for Cancer Market Share by End User (2014-2019)
Figure Global Sales Hyperthermia Treatment for Cancer Market Share by End User in 2018
Figure North America Hyperthermia Treatment for Cancer Sales Growth Rate 2014-2019 (K Units)
Figure North America Hyperthermia Treatment for Cancer Revenue Growth Rate 2014-2019 (Million US$)
Table North America Hyperthermia Treatment for Cancer Sales by Countries (2014-2019) (K Units)
Table North America Hyperthermia Treatment for Cancer Sales Market Share by Countries (2014-2019)
Figure 2018 North America Hyperthermia Treatment for Cancer Sales Market Share by Countries
Table North America Hyperthermia Treatment for Cancer Revenue by Countries (2014-2019) (Million US$)
Table North America Hyperthermia Treatment for Cancer Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Hyperthermia Treatment for Cancer Revenue Market Share by Countries
Figure United States Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure United States Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure Canada Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Table North America Hyperthermia Treatment for Cancer Sales by Product (2014-2019) (K Units)
Table North America Hyperthermia Treatment for Cancer Sales Market Share by Product (2014-2019)
Figure 2018 North America Hyperthermia Treatment for Cancer Market Share by Product
Table North America Hyperthermia Treatment for Cancer Sales by End User (2014-2019) (K Units)
Table North America Hyperthermia Treatment for Cancer Sales Market Share by End User (2014-2019)
Figure 2018 North America Hyperthermia Treatment for Cancer Market Share by End User
Figure Europe Hyperthermia Treatment for Cancer Sales Growth Rate 2014-2019 (K Units)
Figure Europe Hyperthermia Treatment for Cancer Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Hyperthermia Treatment for Cancer Sales by Countries (2014-2019) (K Units)
Table Europe Hyperthermia Treatment for Cancer Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Hyperthermia Treatment for Cancer Sales Market Share by Countries
Table Europe Hyperthermia Treatment for Cancer Revenue by Countries (2014-2019) (Million US$)
Table Europe Hyperthermia Treatment for Cancer Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Hyperthermia Treatment for Cancer Revenue Market Share by Countries
Figure Germany Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure Germany Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure France Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure France Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure UK Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure Italy Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure Russia Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Hyperthermia Treatment for Cancer Sales by Product (2014-2019) (K Units)
Table Europe Hyperthermia Treatment for Cancer Sales Market Share by Product (2014-2019)
Figure 2018 Europe Hyperthermia Treatment for Cancer Market Share by Product
Table Europe Hyperthermia Treatment for Cancer Sales by End User (2014-2019) (K Units)
Table Europe Hyperthermia Treatment for Cancer Sales Market Share by End User (2014-2019)
Figure 2018 Europe Hyperthermia Treatment for Cancer Market Share by End User
Figure Asia Pacific Hyperthermia Treatment for Cancer Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Hyperthermia Treatment for Cancer Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Hyperthermia Treatment for Cancer Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Hyperthermia Treatment for Cancer Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Hyperthermia Treatment for Cancer Sales Market Share by Countries
Table Asia Pacific Hyperthermia Treatment for Cancer Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Hyperthermia Treatment for Cancer Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Hyperthermia Treatment for Cancer Revenue Market Share by Countries
Figure China Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure China Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure Japan Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure Korea Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure India Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure India Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure Australia Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Hyperthermia Treatment for Cancer Sales by Product (2014-2019) (K Units)
Table Asia Pacific Hyperthermia Treatment for Cancer Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Hyperthermia Treatment for Cancer Market Share by Product
Table Asia Pacific Hyperthermia Treatment for Cancer Sales by End User (2014-2019) (K Units)
Table Asia Pacific Hyperthermia Treatment for Cancer Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Hyperthermia Treatment for Cancer Market Share by End User
Figure Central & South America Hyperthermia Treatment for Cancer Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Hyperthermia Treatment for Cancer Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Hyperthermia Treatment for Cancer Sales by Countries (2014-2019) (K Units)
Table Central & South America Hyperthermia Treatment for Cancer Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Hyperthermia Treatment for Cancer Sales Market Share by Countries
Table Central & South America Hyperthermia Treatment for Cancer Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Hyperthermia Treatment for Cancer Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Hyperthermia Treatment for Cancer Revenue Market Share by Countries
Figure Brazil Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Hyperthermia Treatment for Cancer Sales by Product (2014-2019) (K Units)
Table Central & South America Hyperthermia Treatment for Cancer Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Hyperthermia Treatment for Cancer Market Share by Product
Table Central & South America Hyperthermia Treatment for Cancer Sales by End User (2014-2019) (K Units)
Table Central & South America Hyperthermia Treatment for Cancer Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Hyperthermia Treatment for Cancer Market Share by End User
Figure Middle East and Africa Hyperthermia Treatment for Cancer Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Hyperthermia Treatment for Cancer Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Hyperthermia Treatment for Cancer Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Hyperthermia Treatment for Cancer Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Hyperthermia Treatment for Cancer Sales Market Share by Countries
Table Middle East and Africa Hyperthermia Treatment for Cancer Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Hyperthermia Treatment for Cancer Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Hyperthermia Treatment for Cancer Revenue Market Share by Countries
Figure GCC Countries Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Hyperthermia Treatment for Cancer Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Hyperthermia Treatment for Cancer Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Hyperthermia Treatment for Cancer Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Hyperthermia Treatment for Cancer Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Hyperthermia Treatment for Cancer Market Share by Product
Table Middle East and Africa Hyperthermia Treatment for Cancer Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Hyperthermia Treatment for Cancer Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Hyperthermia Treatment for Cancer Market Share by End User
Table Andromedic Sri Company Details
Table Andromedic Sri Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Andromedic Sri Recent Development
Table Celsius42 GmbH Company Details
Table Celsius42 GmbH Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Celsius42 GmbH Recent Development
Table Huahang Company Details
Table Huahang Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Huahang Recent Development
Table Pyrexar Medical Company Details
Table Pyrexar Medical Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pyrexar Medical Recent Development
Table Perseon Medical Company Details
Table Perseon Medical Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Perseon Medical Recent Development
Table Omron Corporation Company Details
Table Omron Corporation Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Omron Corporation Recent Development
Table Sjn AG Yamamoto Vinita Company Details
Table Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sjn AG Yamamoto Vinita Recent Development
Table Global Hyperthermia Treatment for Cancer Sales Forecast by Regions 2019-2025 (K Units)
Table Global Hyperthermia Treatment for Cancer Sales Market Share Forecast by Regions 2019-2025
Table Global Hyperthermia Treatment for Cancer Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Hyperthermia Treatment for Cancer Revenue Market Share Forecast by Regions 2019-2025
Table Global Hyperthermia Treatment for Cancer Sales Forecast by Product 2019-2025 (K Units)
Table Global Hyperthermia Treatment for Cancer Sales Market Share Forecast by Product 2019-2025
Table Global Hyperthermia Treatment for Cancer Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Hyperthermia Treatment for Cancer Revenue Market Share Forecast by Product 2019-2025
Table Global Hyperthermia Treatment for Cancer Sales Forecast by End User 2019-2025 (K Units)
Table Global Hyperthermia Treatment for Cancer Sales Market Share Forecast by End User 2019-2025
Figure North America Hyperthermia Treatment for Cancer Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Hyperthermia Treatment for Cancer Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Hyperthermia Treatment for Cancer Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Hyperthermia Treatment for Cancer Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Hyperthermia Treatment for Cancer Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Hyperthermia Treatment for Cancer Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Hyperthermia Treatment for Cancer Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Hyperthermia Treatment for Cancer Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Hyperthermia Treatment for Cancer Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Hyperthermia Treatment for Cancer Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Hyperthermia Treatment for Cancer Value Chain
Table Hyperthermia Treatment for Cancer Customers List
Table Hyperthermia Treatment for Cancer Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
温熱療法システムの世界市場：市場規模・現状・予測 Hyperthermia is a therapeutic method for the treatment of cancer cells and tumors. The therapy involves heating of tumor up to 42°C, along with the standard therapy named as, chemotherapy or radiation therapy. Hyperthermia systems are used for the treatment of tumors, resisting the follow on medical…- 左室補助装置治療の世界市場：市場規模・現状・予測 Left Ventricular Assist Device is used to treat heart failure, as the bridge to transplant or destination therapy.In 2018, the global Left Ventricular Assist Device Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-…
- 左室補助装置治療の世界市場：市場規模・現状・予測 Left Ventricular Assist Device is used to treat heart failure, as the bridge to transplant or destination therapy.In 2018, the global Left Ventricular Assist Device Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-…
- 膵臓癌治療の世界市場：インサイト・予測 Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. These cancerous cells have the ability to invade other parts of the body.The global Pancreatic Cancer Treatment market is valued at xx million US$ in 2018 and …
- 転移癌治療の世界市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…